Literature DB >> 7251308

Experimental vascular occlusion in hypercholesterolemic rabbits.

H Zauberman, N Livni.   

Abstract

Rabbits fed a diet rich in cholesterol developed hypercholesterolemia and atheromas in the cornea, sclera, iris, ciliary body, and choroid, and a few synchysis scintillans in the vitreous. The fellow eye of these rabbits, in which one nasal vortex vein was occluded, developed far more severe changes in all the above-mentioned eye tissues, especially over the sector of the eye drained by the occluded vein. In hypercholesterolemic rabbits in which a short posterior ciliary artery was occluded, the ischemic area of the choroid was gradually seem to become infiltrated with large crystalline particles. The combination of abnormal blood flow and hypercholesterolemia gives rise to an exaggerated deposition of extravascular lipid material. This experimental model is probably relevant to such human conditions as drusen and lipoid deposition in the choroid and cornea and the formation of asteroid hyalosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251308

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  3 in total

1.  Prevalence and risk factors for epiretinal membranes in a Japanese population: the Hisayama study.

Authors:  Miho Miyazaki; Hidetoshi Nakamura; Michiaki Kubo; Yutaka Kiyohara; Mitsuo Iida; Tatsuro Ishibashi; Yoshiaki Nose
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-07-17       Impact factor: 3.117

2.  Prevalence and risk factors of idiopathic epiretinal membranes in Beixinjing blocks, Shanghai, China.

Authors:  Xiao-feng Zhu; Jin-juan Peng; Hai-dong Zou; Jiong Fu; Wei-wei Wang; Xun Xu; Xi Zhang
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

3.  Oxidative Stress, Lipid Peroxidation, and Loss of Hyaluronic Acid in the Human Vitreous Affected by Synchysis Scintillans.

Authors:  Loredana Bergandi; Oleksii A Skorokhod; Rosalba La Grotta; Evelin Schwarzer; Raffaele Nuzzi
Journal:  J Ophthalmol       Date:  2019-10-30       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.